Sitagliptin: Clinical Trials

97 trials of Sitagliptin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

68 completed, 14 unknown, 12 terminated, 2 withdrawn. 97 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 497Completed 68, Unknown 14, Terminated 12, Withdrawn 2, Recruiting 1

Follow Sitagliptin: new trials by email Literature Review of Sitagliptin trials Research Report on Sitagliptin

Trials (filtered) newest first · largest first

All 97 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Metformin, Dulaglutide, Semaglutide 1.0 mg - Diabetes Mellitus Type 2
Phase 4CompletedFundación para la Investigación del Hospital Clínico de Valencia922025-05-262026-09-04
Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Canagliflozin group, Sitagliptin, Acarbose - Type 2 Diabetes Mellitus, Cognitive Impairment
Phase 4RecruitingFudan University602024-08-192026-07-17
Anti-Diabetic Medications to Fight PD and LBD
Sitagliptin, Dapagliflozin, Placebo - Lewy Body Dementia, Parkinson Disease
Phase 4CompletedMayo Clinic182024-05-072026-01-28
Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes
Sitagliptin, Sitagliptin combined with Beidougen capsule - Type 2 Diabetes
Phase 4UnknownBeijing Chao Yang Hospital202022-12-012023-01-03
The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
Glimepiride, Sitagliptin - Diabetes Mellitus, Type 2, Severe Insulin Deficient Diabetes
Phase 4UnknownPeking University People's Hospital1922022-01-012022-05-23
Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes
METFORMIN, Sitagliptin - Diabetes Mellitus, Type 2, Thyroid Nodule (Benign)
Phase 4UnknownCentre Hospitalier Universitaire de la Guadeloupe902021-01-012020-09-11
Approaches To Therapy Escalation In T2D
DPP-4 inhibitor, SGLT2 inhibitor, SGLT2 inhibitor and DPP-4 inhibitor - Type2 Diabetes
Phase 4WithdrawnLMC Diabetes & Endocrinology Ltd.2019-05-012019-09-27
Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes
Entresto, Sitagliptin, Valsartan - Type2 Diabetes
Phase 4CompletedUniversity of Copenhagen122019-01-252021-05-05
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
Valsartan, LCZ696, Bradykinin - Hypertension
Phase 4TerminatedVanderbilt University Medical Center42018-11-152025-08-03
Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
Sitagliptin, Acarbose - Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
Phase 4UnknownChinese PLA General Hospital3002018-10-012018-07-27
Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease
Empagliflozin, Sitagliptin - Diabetes Mellitus, Coronary Disease
Phase 4CompletedCHEOL WHAN LEE, M.D., Ph.D1002017-08-072019-08-07
Cardiovascular Effects of GLP-1 Receptor Activation
Liraglutide, Sitagliptin, hypocaloric diet - Obesity, PreDiabetes
Phase 4CompletedVanderbilt University Medical Center3292017-05-012022-10-18
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
Saxagliptin, Sitagliptin, Placebo to match saxagliptin - Type 2 Diabetes Mellitus, Heart Failure
Phase 4CompletedAstraZeneca3482017-01-102021-11-08
Treatment of Diabetes in Patients With Systolic Heart Failure
Canagliflozin, Sitagliptin - Heart Failure, Systolic, Diabetes Mellitus, Type 2
Phase 4CompletedVirginia Commonwealth University362016-10-012019-10-29
Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome
Sitagliptin, Lifestyle intervention - PCOS
Phase 4CompletedUniversity Medical Centre Ljubljana302016-08-012017-04-20
The Effect of DPP4 Inhibitor on Vasclular Healing
Sitagliptin, Non DPP-4 Inhibitor - Acute Coronary Syndrome, Diabetes Mellitus, Type 2
Phase 4UnknownChung-Ang University662016-06-012016-06-16
Sitagliptin in Non-Diabetic Patients Undergoing General Surgery
Sitagliptin, Placebo, Supplemental insulin (insulin lispro) - Hyperglycemia
Phase 4CompletedEmory University802016-06-012018-06-27
SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients)
Sitagliptin - Diabetes Mellitus
Phase 4CompletedSichuan Provincial People's Hospital1192016-04-212020-07-30
Drug Transporter Interaction Study PHENTRA_2015_KPUK
pitavastatin, Metformin, digoxin - Healthy
Phase 4CompletedUniversity of Cologne242016-04-012019-09-10
The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Sitagliptin, Placebo - Polycystic Ovary Syndrome
Phase 4CompletedVanderbilt University232016-02-012020-05-08

Showing 20 of 97. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 2 (63)  ·  Diabetes Mellitus (27)  ·  Hyperglycemia (7)  ·  Diabetes Mellitus, Type 1 (5)  ·  Insulin Resistance (5)  ·  Glucose Intolerance (3)  ·  Atherosclerosis (2)  ·  Coronary Disease (2)  ·  Hypertension (2)  ·  Hypoglycemia (2)  ·  Obesity (2)  ·  Acromegaly (1)  ·  Acute Coronary Syndrome (1)  ·  Angina, Unstable (1)  ·  Cognitive Dysfunction (1)

Sponsors

Emory University (5)  ·  Vanderbilt University (4)  ·  AstraZeneca (3)  ·  Lund University (3)  ·  Merck Sharp & Dohme LLC (3)  ·  Novartis Pharmaceuticals (3)  ·  Novo Nordisk A/S (3)  ·  Sanofi (3)  ·  Mayo Clinic (2)  ·  Seoul National University Bundang Hospital (2)  ·  Shanghai Jiao Tong University School of Medicine (2)  ·  The Catholic University of Korea (2)  ·  University of Colorado, Denver (2)  ·  University of Missouri-Columbia (2)  ·  Vanderbilt University Medical Center (2)

Countries

United States (38)  ·  China (10)  ·  South Korea (10)  ·  Germany (8)  ·  India (6)  ·  Japan (5)  ·  Brazil (4)  ·  Spain (4)  ·  Sweden (4)  ·  United Kingdom (4)  ·  Denmark (3)  ·  Netherlands (3)  ·  Thailand (3)  ·  Turkey (Türkiye) (3)  ·  Austria (2)

Top investigators

Guillermo Umpierrez, MD (4)  ·  Guang Ning, MD. PHD (2)  ·  Adrian Vella, M.D. (1)  ·  Amy Warriner, MD (1)  ·  Angelo Avogaro, MD PhD (1)  ·  Anton Cheng, MBBS (1)  ·  Antonio Abbate, MD, PhD (1)  ·  Antonio Ceriello, MD (1)  ·  Asger Lund, MD (1)

Results publications

PMID 11495032, PMID 16400329, PMID 17622601, PMID 18786299, PMID 19723493, PMID 19880582, PMID 20039889, PMID 20357375, PMID 20679179, PMID 21550951, PMID 21923696, PMID 22443183, PMID 22456695, PMID 22683131, PMID 22775317, PMID 22809630, PMID 23186950, PMID 23331498, PMID 23490599, PMID 23579178, PMID 23877988, PMID 25283485, PMID 25457473, PMID 25488587, PMID 26586327, PMID 27038451, PMID 27060930, PMID 27381275, PMID 27405306, PMID 27451030, PMID 27573938, PMID 27585605, PMID 27627981, PMID 27964837, PMID 28145158, PMID 28271251, PMID 28345162, PMID 28671753, PMID 29435776, PMID 29478970, PMID 29607050, PMID 29770541, PMID 30145664, PMID 31189978, PMID 31247117, PMID 31529097, PMID 31733647, PMID 32475838, PMID 32539832, PMID 32719417

NIH funding

K23HL119602 (2), 2008 (1), 2019 (1), 2025 (1), R03DK084089 (1), U54RR014616 (1)